GeneDx Holdings Corp.WGSNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank83
5Y CAGR-11.9%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-11.9%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 57.53% |
| 2024 | -21.53% |
| 2023 | -32.41% |
| 2022 | -18.03% |
| 2021 | 44.65% |
| 2020 | 108.25% |
| 2019 | 0.00% |